89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,722,591 | -33.4% | 435,401 | -18.3% | 0.00% | 0.0% |
| Q2 2023 | $10,096,067 | +21.7% | 532,774 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $8,293,177 | +27.0% | 544,529 | +6.1% | 0.00% | 0.0% |
| Q4 2022 | $6,531,305 | +96.5% | 513,064 | -10.6% | 0.00% | – |
| Q3 2022 | $3,323,000 | +134.3% | 573,964 | +30.4% | 0.00% | – |
| Q2 2022 | $1,418,000 | -10.1% | 440,314 | +5.2% | 0.00% | – |
| Q1 2022 | $1,578,000 | +13.9% | 418,649 | +294.7% | 0.00% | – |
| Q4 2021 | $1,385,000 | +352.6% | 106,062 | +577.9% | 0.00% | – |
| Q3 2021 | $306,000 | -48.1% | 15,645 | -50.4% | 0.00% | – |
| Q2 2021 | $590,000 | -24.6% | 31,517 | -4.8% | 0.00% | – |
| Q1 2021 | $783,000 | +29.6% | 33,113 | +33.6% | 0.00% | – |
| Q4 2020 | $604,000 | -93.9% | 24,792 | -93.6% | 0.00% | -100.0% |
| Q3 2020 | $9,892,000 | +2925.1% | 385,509 | +2247.4% | 0.00% | – |
| Q2 2020 | $327,000 | +23.4% | 16,423 | +56.7% | 0.00% | – |
| Q1 2020 | $265,000 | +1458.8% | 10,483 | +1571.9% | 0.00% | – |
| Q4 2019 | $17,000 | – | 627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |